Stevanato Group (NYSE:STVN) Stock Price Up 1.5% – Here’s What Happened

Stevanato Group S.p.A. (NYSE:STVN)’s share price shot up 1.5% on Wednesday . The company traded as high as €21.80 ($22.95) and last traded at €21.62 ($22.76). Approximately 37,826 shares were traded during trading, a decline of 92% from the average session volume of 500,026 shares. The stock had previously closed at €21.30 ($22.42).

Analyst Ratings Changes

Separately, Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd.

Stevanato Group Trading Up 2.1 %

The company’s 50 day simple moving average is €19.49 and its two-hundred day simple moving average is €19.61. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $6.43 billion, a price-to-earnings ratio of 45.91, a P/E/G ratio of 9.22 and a beta of 0.59.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The business had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. During the same period in the previous year, the business earned $0.16 EPS. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. As a group, research analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

A number of large investors have recently made changes to their positions in STVN. nVerses Capital LLC purchased a new position in shares of Stevanato Group during the third quarter worth $84,000. Raymond James Trust N.A. lifted its holdings in shares of Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after buying an additional 1,613 shares during the period. Oppenheimer Asset Management Inc. boosted its stake in shares of Stevanato Group by 59.2% in the second quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after buying an additional 4,441 shares during the last quarter. Hardy Reed LLC grew its holdings in Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares during the period. Finally, Lindenwold Advisors INC raised its position in Stevanato Group by 13.5% during the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after acquiring an additional 1,415 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.